Selected NCI-Supported Trials

Supported Trials Selected NCI-

That support for NCI promising cancer screening and testing methods describe some of the major clinical trials.

Treatment Trials

NCI-match Test (molecular analysis for the therapy of choice)

Updated: March 13, 2017

NCI match precision medicine trial, the researchers advanced solid tumors and tumor tissue from patients that have stopped responding to lymphomas treated and assigned to treatment arms patients based on molecular profiles disease information about the inspection.

Alchemist lung cancer trials

 Updated: Sep 27, 2016

Completely resected checking non-small cell tumor tissue from patients with lung cancer for Alchemist some types of early stages of the trial of lung cancer cases, EGFR and gene mutations in the ALK gene, and the gene mutations in the surgical use of targeted drug testing for mutations in a combination therapy trial will assign patients with cases of material.

Lung map: Master protocol for squamous cell lung cancer

Updated: March 2, 2016

Lung Cancer master protocol, or lung map, the study will review various study treatment outcomes for patients with cancer assigned squamous cell lung combinations of drugs based on the results of genomic profiling of tumor material about it a combination.

ALTTO Breast Cancer Trial

Updated: June 1, 2014

An adjuvant combination of Lapatinib and / or Trastuzumab Treatment Optimization, or ALTTO about content, layout, one that targets the agents will compare lapatinib and trastuzumab, or a combination of studies in HER2-positive adjuvant therapy for breast cancer.

TAILORx Breast Cancer Trial

Updated: Sep 28, 2015

The trial for the treatment of individual options (RX), or TAILORx, which has a molecular test will check whether most are appropriate and assigned to women with breast cancer in the early stage of effective treatment a combination of materials.

Test And Screening Test

National lung screening test

The National Lung Screening Trial (NLST), a scan or chest X-ray study sponsored by the National Cancer Institute, about the risk of lung cancer, less doses of helical men and women about the screen.

Prostate, lung, colon and ovarian cancer screening trial

Some cancer screening tests for prostate, lung, colon, and ovaries whether to reduce deaths from cancer that a large-scale clinical trial to determine. Moreover, what are you going to answer other questions about cancer screening tests and several epidemiologic studies and ancillary.